Jean-Claude Bizec

The Discovery of <i>N</i>-(1-Methyl-5-(trifluoromethyl)-1<i>H</i>-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1<i>H</i>-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration

Christopher M. Adams, Karen Anderson, Gerald D. Artman et al. · Journal of Medicinal Chemistry · 2018 · 41 citations · Full text

Medicine, Ophthalmology, Pharmacology +16

Pharmacokinetic and technical comparison of Sandostatin® LAR® and other formulations of long-acting octreotide

Holger Petersen, Jean-Claude Bizec, Helmut Schuetz et al. · BMC Research Notes · 2011 · 32 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Calcium-dependent regulation of adenylate cyclase and phosphodiesterase activities in bovine lens: Involvement of lens calmodulin

Jean-Claude Bizec, J Klethi, P. Mandel · Experimental Eye Research · 1985 · 12 citations

Medicine, Biochemistry, Ophthalmology +10

Modulation of rod cyclic GMP-phosphodiesterase activity by anthocyanidin derivatives

N. Virmaux, Jean-Claude Bizec, Gérard Nullans et al. · Biochemical Society Transactions · 1990 · 11 citations

Life Sciences, Neuroscience, Pharmacology +12